4January CT, Wann LS, Alpert JS,et al.2014 AHA/ACC/ HRS guideline for the management of patients with atrial fibrillation[J].J Am Coll Cardiol,2014,64(21): 1-76.
5Wolf PA, Benjamin EJ, Belanger AJ,et al.Secular trends in the prevalence of atrial fibrillation: The Framingham Study[J].Am Heart J, 1996 ,131(4): 790-795.
6Go AS, Hylek EM,Phillips KA, et al.Prevalence of diag- nosed atrial fibrillation in adults:National implications for rhythm management and stroke prevention: the AnTico- agulation and Risk Factors in Atrial Fibrillation(ATRIA)Study[J].JAMA,2001,285(18):2370-2375.
7Camm AJ,Kirchhof P,Lip GY, et al.Guidelines for the management of atrial fibrillation the task force for the management of atrial fibrillation of the European Society of Cardiology(ESC)[J].Europace, 2010,12(10): 1360-1420.
8Mark J, Alberts, John W, et aL Antithrombotic therapy for stroke prevention in non-valvular atrial fi brillation.[EB/OL].www.thelancet.com/neurology ,2012-12.
9Ogilvie IM,Weiner SA,Cowell W,et al.Ischaemic stroke and bleeding rates in " real-world" atrial fibrillation pa- tients[J], Thromb Haemost,2011,106(1):34-44.
10Oldgren J,Healey JS, Ezekowitz M,et al.Variations in cause and management of atrial fibrillation in a prospec- tive registry of 15400 emergency department patients in 46 countries:the RE-LY Atrial Fibrillation Registry[J], Circulation,2014,129(15):1568-1576.
